Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
EV/Net Sales

    Back to All Ratios
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Mid Cap Stocks
AD     Remove this Ad

GLENMARK PHARMACEUTICALS Last 5 Year EV/Net Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Net Sales(x) 3.302.231.411.201.52

What is the latest EV/Net Sales ratio of GLENMARK PHARMACEUTICALS ?

The latest EV/Net Sales ratio of GLENMARK PHARMACEUTICALS is 3.30 based on Mar2025 Consolidated results.
Year EV/Net Sales
Mar20253.30
Mar20242.23
Mar20231.41
Mar20221.20
Mar20211.52

How is EV/Net Sales of GLENMARK PHARMACEUTICALS Trending?

Years EV/Net Sales % Change
Mar2025 3.3
47.98
Mar2024 2.23
58.16
Mar2023 1.41
17.50
Mar2022 1.2
-21.05
Mar2021 1.52 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare EV/Net Sales ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹61,549.2 Cr 0.3% 7.5% 46.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹426,470.0 Cr -0.3% 3.1% 2.2% Stock Analytics
DIVIS LABORATORIES ₹161,996.0 Cr 0.5% -2.9% 5.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,440.0 Cr 0.1% 1.4% 37.6% Stock Analytics
DR REDDYS LABORATORIES ₹108,417.0 Cr 1.9% 1.4% 10.7% Stock Analytics
CIPLA ₹101,445.0 Cr -3.3% -6.9% -17% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

0.3%

7.5%

46.6%

SENSEX

-0%

-10.7%

1%


You may also like the below Video Courses